Financials

  • Market Capitalization 5.57 B
  • Employee 103
  • Founded 2018
  • CEO N/A
  • Website www.erasca.com
  • Headquarter Delaware, United States
  • FIGI BBG00MTSR883
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-8.45
Relación precio/flujo de caja
361.71

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1198
LGND
Ligand Pharmaceuticals Incorporated - Common Stock
309.25 USD-2.21%-2.80%+21.27%+65.27%6.20 B USD
1246
BLTE
Belite Bio Inc - American Depositary Shares
147.03 USD-1.54%-5.14%+4.41%+128.59%5.78 B USD
1282
DNTH
Dianthus Therapeutics, Inc. - Common Stock
98.64 USD+1.07%+5.68%+18.29%+388.56%5.39 B USD
1301
TVTX
Travere Therapeutics, Inc. - Common Stock
56.29 USD-0.53%-2.58%+6.63%+95.66%5.23 B USD

Noticias